ARTICLE | Distillery Therapeutics
Inhibiting NR4A1, NR4A2 and N4RA3 in CAR Ts to enhance efficacy in solid tumors
March 5, 2019 10:36 PM UTC
INDICATION: Melanoma; colorectal cancer ...
BCIQ Company Profiles
Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
INDICATION: Melanoma; colorectal cancer ...
BCIQ Company Profiles
BCIQ Company Profiles